drugset / Trial / NCT07043634
A Study to Evaluate the Effect of Food or no Food on the Bioavailability of an Extended Release (ER) Torsemide and Spironolactone Fixed Dose Combination (FDC) Tablet in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study will examine comparative bioavailability of single dose of a fixed dose combination (FDC) of extended release Torsemide and Spironolactone given with or without food in healthy adult subjects.
Timeline
- Start
- 2025-06-15
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Spironolactone | Small molecule | 30 mg | Oral |
| Subject | Torsemide | Other / unclassified | 24 mg | Oral |
Indications
No indication recorded.